title: Will obesity increase the proportion of children and adolescents recommended for a statin?
authors.affiliation: Department of Pediatrics, University of Toronto, Labatt Family Heart Centre, The Hospital for Sick Children, Toronto, Ontario, Canada (B.W.M., P.N.T.); and the Department of Pediatrics, University of Rochester Medical Center, Rochester, NY (R.-E.W.K.).
authors.forename: Brian W
authors.initials: BW
authors.lastname: McCrindle
authors.forename: Pascal N
authors.initials: PN
authors.lastname: Tyrrell
authors.forename: Rae-Ellen W
authors.initials: RE
authors.lastname: Kavey
mesh_terms: D000293:Adolescent; D002648:Child; D003430:Cross-Sectional Studies; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008297:Male; D009749:Nutrition Surveys / Q000706:statistics & numerical data; D009765:Obesity / Q000097:blood / Q000453:epidemiology*; D017410:Practice Guidelines as Topic / Q000592:standards; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids
keywords: hypercapnia; hypercholesterolemia; obesity; pediatrics; statins, HMG-CoA